High Risk for Persistent Opioid Use in Young People With Sarcoma High Risk for Persistent Opioid Use in Young People With Sarcoma
Roughly one quarter of adolescents and young adults with sarcoma will continue to use opioids after their cancer treatment, a new study shows.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 8, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Triple Therapy May Reduce the Risk for Tumors in the Elderly Triple Therapy May Reduce the Risk for Tumors in the Elderly
A combination of high-dose vitamin D, omega-3 fatty acids, and a simple at-home training program reduces the risk of cancer by 61% in healthy people over age 70 years, data indicate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 7, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pseudocirrhosis in Breast Cancer May Signal Liver Metastases Pseudocirrhosis in Breast Cancer May Signal Liver Metastases
A large case series of metastatic breast cancer patients with pseudocirrhosis found that almost all such patients had hormone receptor –positive disease as well as extensive liver metastases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 7, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Do Minority Patients Receive the Same Quality of Cancer Care? Do Minority Patients Receive the Same Quality of Cancer Care?
Learn about the sociodemographic, economic, and research factors that contribute to disparities in cancer care, and how physicians can help reduce these differences.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 7, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

Iatrogenic Tumor Seeding via Colonoscopy Unlikely Iatrogenic Tumor Seeding via Colonoscopy Unlikely
Biopsy of noncancerous sites after biopsy of a colorectal cancer confers no meaningfully higher risk of metachronous cancer, despite biologic plausibility.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 7, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Targeted Therapy an'Important Advance' in Childhood Glioma Targeted Therapy an'Important Advance' in Childhood Glioma
Combining dabrafenib with trametinib markedly improved response rates and delayed progression over standard-of-care chemotherapy in pediatric BRAF V600-mutant low-grade glioma in a phase 2 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 6, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First-Line Treatment in Newly Diagnosed Multiple Myeloma First-Line Treatment in Newly Diagnosed Multiple Myeloma
Patients who received a transplant immediately after triplet therapy showed a highly significant 21.4-month gain in median progression-free survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 5, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

International Trial Finds Best Regimen for Ewing  Sarcoma International Trial Finds Best Regimen for Ewing  Sarcoma
The rEECur international collaboration has helped answer questions about the best approach to treating a rare disease for which randomized trials were previously lacking.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 5, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Panitumumab Beats Bevacizumab in Left-Sided mCRC Panitumumab Beats Bevacizumab in Left-Sided mCRC
The first trial comparing panitumumab or bevacizumab plus standard chemotherapy has shown that the former significantly improves survival in left-sided Ras wild type metastatic colorectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 5, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Adagrasib Shows Durable Benefit in KRAS-Mutated NSCLC Adagrasib Shows Durable Benefit in KRAS-Mutated NSCLC
Adagrasib shows durable clinical benefit in previously treated, advanced KRASG12C-mutated non-small cell lung cancer, including patients with brain metastases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 4, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Improved Survival in Subset of Advanced Pancreatic Cancer Improved Survival in Subset of Advanced Pancreatic Cancer
Adding nimotuzumab to gemcitabine significantly improved survival outcomes in a subset of patients with KRAS wild-type advanced pancreatic cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 4, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Simple Formula May Catch Insulinomas Without Extensive Workup Simple Formula May Catch Insulinomas Without Extensive Workup
The findings suggest it might be possible to skip the 72-hour fasting plasma glucose test. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 4, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Bariatric Surgery Cuts Risk of Developing and Dying From Cancer Bariatric Surgery Cuts Risk of Developing and Dying From Cancer
The magnitude of the benefit was large and dose-dependent, with more weight loss associated with greater reduction in cancer risk, according to results from the SPLENDID study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Acneiform Eruptions More Severe With Targeted Therapy Combos Acneiform Eruptions More Severe With Targeted Therapy Combos
The eruptions experienced by patients with colorectal cancer are particularly bad with EGFR and MEK inhibitor combinations. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2022 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Which Malnutrition Criteria to Use in Gynecologic Cancers? Which Malnutrition Criteria to Use in Gynecologic Cancers?
New research aims to identify the ' most relevant definitions of malnutrition ' for assessing postoperative outcomes in three gynecologic cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news